During the past decade, Uniwersytecki Szpital Dzieciecy w Krakowie conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 5 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 5 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uniwersytecki Szpital Dzieciecy w Krakowie" #1 sponsor was "Takeda" with 8 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Actelion" with 2 trials sponsored, "Amgen" with 2 trials sponsored and "Société des Produits Nestlé (SPN)" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uniwersytecki Szpital Dzieciecy w Krakowie" #1 collaborator was "Takeda Development Center Americas, Inc." with 3 trials as a collaborator, "Celerion" with 1 trials as a collaborator, "Innovative Therapies For Children with Cancer Consortium" with 1 trials as a collaborator, "Syneos Health" with 1 trials as a collaborator and "Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) - Study Design & Execution Collaborator" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Uniwersytecki Szpital Dzieciecy w Krakowie" are "Colitis, Ulcerative" (4 trials), "Crohn's Disease" (3 trials), "Crohn Disease" (2 trials), "Hypertension, Pulmonary" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Uniwersytecki Szpital Dzieciecy w Krakowie" in a lesser frequency.

Most popular intervention types in "Uniwersytecki Szpital Dzieciecy w Krakowie" are "Drug" (22 trials), "Other" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Vedolizumab" (3 trials), "Dexlansoprazole" (2 trials), "Ustekinumab" (2 trials) and "6-Mercaptopurine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uniwersytecki Szpital Dzieciecy w Krakowie" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Uniwersytecki Szpital Dzieciecy w Krakowie". 1 are not yet recruiting, 11 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Uniwersytecki Szpital Dzieciecy w Krakowie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Uniwersytecki Szpital Dzieciecy w Krakowie, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Uniwersytecki Szpital Dzieciecy w Krakowie has several departments that took part in Clinical trials: "University Children's Hospital" - 5 trials